Cases of transfusion-transmitted babesiosis occurring in nonendemic areas: a diagnostic dilemma

Transfusion

Volumn 57, Issue 10, 2017, Pages 2348-2354

  LeBel, David P ^a   Moritz, Erin D ^b   O'Brien, Jennifer J ^c   Lazarchick, John ^a   Tormos, Lee Marie ^a   Duong, Angie ^a   Fontaine, Magali J ^c   Squires, Jerry E ^a   Stramer, Susan L ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b AMERICAN RED CROSS   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; AZITHROMYCIN; CLINDAMYCIN; DOXYCYCLINE; ANTIINFECTIVE AGENT;

ADULT; ARTICLE; ASYMPTOMATIC INFECTION; BABESIA MICROTI; BLOOD DONOR; BLOOD SMEAR; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CLINICAL ARTICLE; DELAYED DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; HUMAN; INFANT; MALE; MARYLAND; PIROPLASMOSIS; PYREXIA IDIOPATHICA; RECIPIENT; SOUTH CAROLINA; TRANSFUSION TRANSMITTED BABESIOSIS; BABESIOSIS; CASE REPORT; ERYTHROCYTE TRANSFUSION; FEVER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; TRANSMISSION; UNITED STATES;

ADULT; ANTI-BACTERIAL AGENTS; BABESIOSIS; BLOOD DONORS; BLOOD TRANSFUSION; DIAGNOSIS, DIFFERENTIAL; ERYTHROCYTE TRANSFUSION; FEVER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; UNITED STATES;

EID: 85027177997     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.14246     Document Type: Article

References (39)

1. Skrabalo Z, Deanovic Z. Piroplasmosis in man; report of a case. Doc Med Geogr Trop 1957;9:11-6.
2. Western KA, Benson GD, Gleason NN, et al. Babesiosis in a Massachusetts resident. N Engl J Med 1970;283:854-6.
3. Kjemtrup AM, Conrad PA. Human babesiosis: an emerging tick-borne disease. Int J Parasitol 2000;30:1323-37.
4. Vannier E, Krause PJ. Human babesiosis. N Engl J Med 2012;366:2397-407.
5. Vannier E, Gewurz BE, Krause PJ. Human babesiosis. Infect Dis Clin North Am 2008;22:469-88.
6. Cornett JK, Malhotra A, Hart D. Vertical transmission of babesiosis from a pregnant, splenectomized mother to her neonate. Infect Dis Clin Pract 2012;20:408
7. Herwaldt BL, Linden JV, Bosserman E, et al. Transfusion-associated babesiosis in the United States: a description of cases. Ann Intern Med 2011;155:509-19.
8. Fang DC, McCullough J. Transfusion-transmitted Babesia microti. Transfus Med Rev 2016;30:132-8.
9. Hatcher JC, Greenberg PD, Antique J, et al. Severe babesiosis in Long Island: review of 34 cases and their complications. Clin Infect Dis 2001;32:1117.
10. Pearson RD. Other protozoal diseases. In: Goldman L, Ausiello D, editors. Cecil textbook of medicine. 22nd ed. Philadelphia, PA: Saunders; 2004. p. 2099–101.
11. White DJ, Talarico J, Chang HG, et al. Human babesiosis in New York State: Review of 139 hospitalized cases and analysis of prognostic factors. Arch Intern Med 1998;158:2149-54.
12. Healy GR, Ruebush TK 2nd. Morphology of Babesia microti in human blood smears. Am J Clin Pathol 1980;73:107-9.
13. Persing DH, Mathiesen D, Marshall WF, et al. Detection of Babesia microti by polymerase chain reaction. J Clin Microbiol 1992;30:2097-103.
14. Krause PJ, Ryan R, Telford S 3rd, et al. Efficacy of immunoglobulin M serodiagnostic test for rapid diagnosis of acute babesiosis. J Clin Microbiol 1996;34:2014-6.
15. Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006;43:1089-134.
16. Simonsen KA, Harwell JI, Lainwala S. Clinical presentation and treatment of transfusion-associated babesiosis in premature infants. Pediatrics 2011;128:e1019-24.
17. Raju M, Salazar JC, Leopold H, et al. Atovaquone and azithromycin treatment for babesiosis in an infant. Pediatr Infect Dis J 2007;26:181-3.
18. Krause PJ, Lepore T, Sikand VK, et al. Atovaquone and azithromycin for the treatment of babesiosis. N Engl J Med 2000;343:1454-8.
19. Spaete J, Patrozou E, Rich JD, et al. Red cell exchange transfusion for babesiosis in Rhode Island. J Clin Apher 2009;24:97-105.
20. Krause PJ, Spielman A, Telford SR 3rd, et al. Persistent parasitemia after acute babesiosis. N Engl J Med 2007;356:2313-9.
21. Ruebush TK 2nd, Juranek DD, Chisholm ES, et al. Human babesiosis on Nantucket Island. Evidence for self-limited and subclinical infections. N Engl J Med 1977;297:825-7.
22. Leiby DA. Transfusion-transmitted Babesia spp.: bull's-eye on Babesia microti. Clin Microbiol Rev 2011;24:14-28.
23. Gubernot DM, Lucey CT, Lee KC, et al. Babesia infection through blood transfusions: reports received by the US Food and Drug Administration, 1997-2007. Clin Infect Dis 2009;48:25-30.
24. Adams DA, Thomas KR, Jajosky, et al. Summary of notifiable infectious diseases and conditions—United States, 2014. MMWR Morb Mortal Wkly Rep 2016;63:1-152.
25. Moritz ED, Winton CS, Tonnetti L, et al. Screening for Babesia microti in the US blood supply. N Engl J Med 2016;375:2236-45.
26. Moritz ED, Winton CS, Johnson ST, et al. Investigational screening for Babesia microti in a large repository of blood donor samples from nonendemic and endemic areas of the United States. Transfusion 2014;54:2226-36.
27. Centers for Disease Control and Prevention (CDC). Surveillance for babesiosis—United States, 2014 annual summary. Atlanta (GA): US Department of Health and Human Services, CDC; 2016 [2017 Jan 16]. Available from: https://www.cdc.gov/parasites/babesiosis/resources/babesiosis_surveillance_summary_2016.pdf.
28. South Carolina Department of Health and Environmental Control. South Carolina annual report on reportable conditions, 2012-2013. Charleston (SC): Department of Health and Environmental Control; 2014 [cited 2017 Jan 16]. Available from: http://www.scdhec.gov/Health/docs/Annual%20Report%202012-2013.pdf.
29. Meissner EG, McGilicuddy JW, Squires J, et al. Across state lines: fulminant Babesia microti infection in a liver transplant recipient. Transpl Infect Dis [Epub ahead of print 2017 Jun 23].
30. Lieby DA. Transfusion-associated babesiosis: shouldn't we be ticked off? Ann Intern Med 2011;155:556-7.
31. Jacoby GA, Hunt JV, Kosinski KS, et al. Treatment of transfusion-transmitted babesiosis by exchange transfusion. N Engl J Med 1980;303:1098-100.
32. Cable RG, Trouern-Trend J. Tickborne infections. 1st ed. Boca Raton (FL): CRC Press; 2001.
33. Johnson ST, Cable RG, Leiby DA. Lookback investigations of Babesia microti-seropositive blood donors: seven-year experience in a Babesia-endemic area. Transfusion 2012;52:1509-16.
34. Levin AE, Williamson PC, Bloch EM, et al. Serologic screening of United States blood donors from Babesia microti using an investigational enzyme immunoassay. Transfusion 2016;56:1866-74.
35. Grifols. Investigational new drug application is now effective for Babesia screening in blood donations using Grifols Procleix Panther system in the US [press release] [cited 2017 May 23]. Available from: http://www.grifolsusa.com/en/web/eeuu/view-news/-/new/investigational-new-drug-application-is-now-effective-for-babesia-screening-in-blood-donations-using-grifols-procleix-panther-system-in-the-us.
36. Simon MS, Leff JA, Pandya A, et al. Cost-effectiveness of blood donor screening for Babesia microti in endemic regions of the United States. Transfusion 2014;54:889-99.
37. Goodell AJ, Bloch EM, Krause PJ, et al. Costs, consequences, and cost-effectiveness of strategies for Babesia microti donor screening of the US blood supply. Transfusion 2014;54:2245-57.
38. Bish EK, Moritz ED, El-Amine H, et al. Cost-effectiveness of Babesia microti antibody and nucleic acid blood donation screening using results from prospective investigational studies. Transfusion 2015;55:2256-71.
39. Ness PM, Lipton KS. Selective transfusion protocols: errors and accidents waiting to happen. Transfusion 2001;41:7113-5.